188 related articles for article (PubMed ID: 30389231)
1. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression.
Kaltenecker D; Themanns M; Mueller KM; Spirk K; Suske T; Merkel O; Kenner L; Luís A; Kozlov A; Haybaeck J; Müller M; Han X; Moriggl R
Cytokine; 2019 Dec; 124():154569. PubMed ID: 30389231
[TBL] [Abstract][Full Text] [Related]
2. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.
Corbit KC; Wilson CG; Lowe D; Tran JL; Vera NB; Clasquin M; Mattis AN; Weiss EJ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393852
[TBL] [Abstract][Full Text] [Related]
4. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism.
Baik M; Yu JH; Hennighausen L
Ann N Y Acad Sci; 2011 Jul; 1229():29-37. PubMed ID: 21793836
[TBL] [Abstract][Full Text] [Related]
6. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.
Mueller KM; Themanns M; Friedbichler K; Kornfeld JW; Esterbauer H; Tuckermann JP; Moriggl R
Mol Cell Endocrinol; 2012 Sep; 361(1-2):1-11. PubMed ID: 22564914
[TBL] [Abstract][Full Text] [Related]
7. Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
Shi SY; Luk CT; Schroer SA; Kim MJ; Dodington DW; Sivasubramaniyam T; Lin L; Cai EP; Lu SY; Wagner KU; Bazinet RP; Woo M
J Biol Chem; 2017 Mar; 292(9):3789-3799. PubMed ID: 28100771
[TBL] [Abstract][Full Text] [Related]
8. High concentrations of fatty acids and β-hydroxybutyrate impair the growth hormone-mediated hepatic JAK2-STAT5 pathway in clinically ketotic cows.
Du X; Zhu Y; Peng Z; Cui Y; Zhang Q; Shi Z; Guan Y; Sha X; Shen T; Yang Y; Li X; Wang Z; Li X; Liu G
J Dairy Sci; 2018 Apr; 101(4):3476-3487. PubMed ID: 29398030
[TBL] [Abstract][Full Text] [Related]
9. CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway.
Li P; Shan K; Liu Y; Zhang Y; Xu L; Xu L
Dig Dis Sci; 2019 Jan; 64(1):113-122. PubMed ID: 30259280
[TBL] [Abstract][Full Text] [Related]
10. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
[TBL] [Abstract][Full Text] [Related]
11. mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
[TBL] [Abstract][Full Text] [Related]
12. NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition.
Vesting AJ; Jais A; Klemm P; Steuernagel L; Wienand P; Fog-Tonnesen M; Hvid H; Schumacher AL; Kukat C; Nolte H; Georgomanolis T; Altmüller J; Pasparakis M; Schmidt A; Krüger M; Supprian MS; Waisman A; Straub BK; Raschzok N; Bernier M; Birkenfeld AL; Hövelmeyer N; Brüning JC; Wunderlich FT
Mol Metab; 2022 Dec; 66():101626. PubMed ID: 36356831
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5.
Yu J; Zhao L; Wang A; Eleswarapu S; Ge X; Chen D; Jiang H
Endocrinology; 2012 Feb; 153(2):750-8. PubMed ID: 22166977
[TBL] [Abstract][Full Text] [Related]
14. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
[TBL] [Abstract][Full Text] [Related]
15. Liver-specific deletion of the signal transducer and activator of transcription 5 gene aggravates fatty liver in response to a high-fat diet in mice.
Baik M; Nam YS; Piao MY; Kang HJ; Park SJ; Lee JH
J Nutr Biochem; 2016 Mar; 29():56-63. PubMed ID: 26895665
[TBL] [Abstract][Full Text] [Related]
16. Mono-2-ethylhexyl phthalate (MEHP) promoted lipid accumulation via JAK2/STAT5 and aggravated oxidative stress in BRL-3A cells.
Zhang Y; Wang S; Zhao T; Yang L; Guo S; Shi Y; Zhang X; Zhou L; Ye L
Ecotoxicol Environ Saf; 2019 Nov; 184():109611. PubMed ID: 31491605
[TBL] [Abstract][Full Text] [Related]
17. Disruption of JAK2 in adipocytes impairs lipolysis and improves fatty liver in mice with elevated GH.
Nordstrom SM; Tran JL; Sos BC; Wagner KU; Weiss EJ
Mol Endocrinol; 2013 Aug; 27(8):1333-42. PubMed ID: 23782652
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice.
Themanns M; Mueller KM; Kessler SM; Golob-Schwarzl N; Mohr T; Kaltenecker D; Bourgeais J; Paier-Pourani J; Friedbichler K; Schneller D; Schlederer M; Zebedin-Brandl E; Terracciano LM; Han X; Kenner L; Wagner KU; Mikulits W; Kozlov AV; Heim MH; Gouilleux F; Haybaeck J; Moriggl R
Sci Rep; 2016 Oct; 6():34719. PubMed ID: 27713471
[TBL] [Abstract][Full Text] [Related]
19. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
[TBL] [Abstract][Full Text] [Related]
20. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
